Transplantation Proceedings

Presidential address: Why Xenotransplantation?
pp. 833-833(1)
Author: Groth C.G.

Opening address: Welcome to Nagoya¹
pp. 835-835(1)
Author: Takagi H.

Acute vascular rejection
pp. 839-840(2)
Author: Platt J.L.

Immunohistological study on the graft following all O- and xenotransplantation in recipients with preformed antibody
pp. 841-842(2)
Authors: Morozumi K.; Kobayashi T.; Katoh M.; Oikawa T.; Ohtsuka Y.; Itoh A.; Usami T.; Takeuchi O.; Koyama K.; Kimura G.; Takeda A.; Yoshida A.; Haba T.; Tomonaga Y.; Uchida K.; Yokoyama I.; Hayashi S.; Nagasaka Y.; Namii S.; Nakao A.; Takagi H.

Differential expression of -Gal epitopes on pig and mouse organs
pp. 843-843(1)
Authors: Tanemura M.; Galili U.

Anti-Galactose-(1,3)Galactose antibody production in 1,3-Galactosyltransferase gene knockout mice after xeno- and allotransplantation
pp. 844-845(2)
Authors: Chong A.S.-F.; Blinder L.; Ma L.; Yin D.; Shen J.; Williams J.W.; Byrne G.; Schwarz A.; Diamond L.S.; Logan J.E.

Genes coding for anti-Gal in knock-out mice for the 1,3Galactosyltransferase gene: analysis by hybridomas
pp. 846-847(2)
Authors: Chen Z.C.; Galili U.

Ganglioside xenoantigens in pig lymphocytes and aorta
pp. 848-850(3)
Authors: Magnusson S.; Hallberg E.; Mansson J.-E.; Romano E.; Rydberg L.; Strokan V.; Svensson L.; Breimer M.E.

Identification of non-Gal xenoantigens on porcine red blood cells
pp. 851-854(4)
Author: Zhu A.

Effect of various glycosyltransferases on the swine xenoantigen
pp. 855-855(1)
Authors: Koma M.; Miyagawa S.; Honke K.; Ikeda Y.; Koyota S.; Murase A.; Tsuji S.; Miyoshi S.; Matsuda H.; Shirakura R.; Taniguchi N.

In vitro and in vivo inhibition of anti-gal secreting cells
pp. 856-856(1)
Authors: Xu Y.; Ryan D.; Wu C.; Kiessling L.; Xu J.; Morgan P.; Vitetta E.; White-Scharf M.E.; Thall A.D.

Identification of B cells with receptors for -Gal epitopes (Gal 1-3Gal1-4GlcNac-R) in xenograft recipients
pp. 857-858(2)
Authors: Tanemura M.; Galili U.

Recombinant Gal1,3Gal-substituted mucin/immunoglobulin chimeras: a superior absorber of anti-pig antibodies
pp. 859-859(1)
Authors: Liu J.; Holgersson J.

Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 275 aphereses in baboons
pp. 860-860(1)
Authors: Watts A.; Foley A.; Awwad M.; Treter S.; Lambrigts D.; Buhler L.; Gojo S.; Basker M.; Oravec G.; Sachs D.H.; Andrews D.; Cooper D.K.C.

Absence of cross-reactivity between xenoantibodies directed against concordant or discordant xenoantigens in rats
pp. 861-861(1)
Authors: Ji P.; Xia G.L.; Waer M.

A simple and sensitive quantitative method for determining xenoreactive antibody titers in the mouse-to-rat cardiac transplantation model
pp. 862-863(2)
Authors: Haga M.; Hirahara H.; Tsuchida M.; Watanabe T.; Takekubo M.; Hayashi J.

Prolonged survival of guinea-pig-to-rat heart xenografts following complement depletion and B-cell-directed immunosuppression by malononitrilamide
pp. 864-865(2)
Authors: Meyer zu Vilsendorf A.; Nagel E.; Link C.; Jorns A.; Kohl J.

Analysis of antiporcine antibodies in cynomolgus recipients of porcine kidneys on cyclophosphamide-based immunosuppression
pp. 866-866(1)
Authors: Kunz R.; Loss M.; Schwinzer R.; Rensing S.; Kaup J.; Klempnauer J.; Winkler M.

Development of a donor-specific, automated, and cost-effective cytotoxicity assay for human serum on primary porcine cells
pp. 867-868(2)
Authors: Laaf G.; Schuster S.; Martin U.; Steinhoff G.; Haverich A.; Simon A.R.

Xenoreactivity of fetal and neonatal baboon intracellular antibody against the pig
pp. 869-871(3)
Authors: Xu H.; Gundry S.R.; Bailey L.L.

Human natural antibodies that recognize nonGal antigens on porcine red blood cells
pp. 872-873(2)
Authors: Zhu A.; Hurst R.

Immunogenicity of Hanganutziu-Deicher antigens in pig-to-human xenotransplantation
pp. 874-874(1)
Authors: Kobayashi T.; Suzuki A.; Yokoyama I.; Abe M.; Hayashi S.; Nagasaka T.; Namii Y.; Kato T.; Tokoro T.; Liu D.; Nakao A.; Matsuda H.; Morozumi K.; Breimer M.E.; Rydberg L.; Groth C.G.; Tibell A.; Korsgren O.; Takagi H.

Xenoantigenacity of Chinese Neijiang pig-related to xenotransplantation
pp. 875-876(2)
Authors: Li Y.; Li T.; Bu H.; Cheng J.; Chen Y.; Yang Z.

-Gal and -Gal are preferentially expressed on porcine cardiac microvascular endothelium²
pp. 877-878(2)
Authors: Chen R.H.; Kadner A.; Mitchell R.N.; Santerre D.H.; Adams D.H.

Comparison of immunoadsorption by GAL- 1,3- Gal-paa disaccharide columns and by extracorporeal kidney perfusion in the setting of discordant xenogeneic lung transplantation
pp. 879-881(3)
Authors: Schroder C.; Martin U.; Simon A.; Laaff G.; Wiebe K.; Galanina O.; Haverich A.; Lapin B.; Steinhoff G.

Natural anti-Gal antibodies constitute 0.2% of intravenous immunoglobulin and are equally retained on a synthetic disaccharide column or on an immobilized natural glycoprotein
pp. 882-883(2)
Authors: Barreau N.; Blancho G.; Boulet C.; Martineau A.; Vusio P.; Liaigre J.; Bovin N.; Bouhours D.; Bouhours J.-F.

Removal of terminal -Galactosyl residues by endo--galactosidase C, a potent endoglycosidase which acts under physiological pH conditions
pp. 884-884(1)
Authors: Ogawa H.; Muramatsu H.; Nagasaka T.; Kurosawa N.; Kobayashi T.; Namii Y.; Hayashi S.; Yokoyama I.; Nakao A.; Takagi H.; Muramatsu T.

Human serum induces apoptosis of isolated mouse cardiomyocytes in vitro
pp. 885-887(3)
Authors: Shimada M.; Ogiwara M.; Kadokura M.; Asano H.; Kyo S.; Yokote Y.; Omoto R.; Lucien J.; Coles J.G.

Neutralization of anti-Galactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons
pp. 888-889(2)
Authors: Manez R.; Crespo F.; Gonzalez E.; Centeno A.; Juffe A.; Arnal F.; Cozzi E.; White D.J.G.; Duthaler R.; Kinzy W.; Oehrlein R.; Katopodis A.

Augmented anti-Galactosyl antibodies in adult baboons in the setting of intestinal parasitic infections are not associated with higher titers of anti-pig hemolytic antibody
pp. 890-891(2)
Authors: Lopez E.; Centeno A.; Crespo F.; Juffe A.; Filgueira P.; Veira P.; Warner R.; Katopodis A.; Manez R.

Efficiency of transgenesis using sperm-mediated gene transfer: generation of hDAF transgenic pigs
pp. 892-894(3)
Authors: Lazzereschi D.; Forni M.; Cappello F.; Bacci M.L.; Di Stefano C.; Marfe G.; Giancotti P.; Renzi L.; Wang H.J.; Rossi M.; Della Casa G.; Pretagostini R.; Frati G.; Bruzzone P.; Stassi G.; Stoppacciaro A.; Turchi V.; Cortesini R.; Sinibaldi P.; Frati L.; Lavitrano M.

hDAF expression in hearts of transgenic pigs obtained by sperm-mediated gene transfer
pp. 895-896(2)
Authors: Cappello F.; Stassi G.; Lazzereschi D.; Renzi L.; Di Stefano C.; Marfe G.; Giancotti P.; Wang H.J.; Stoppacciaro A.; Forni M.; Bacci M.L.; Turchi V.; Sinibaldi P.; Rossi M.; Bruzzone P.; Pretagostini R.; Della Casa G.; Cortesini R.; Frati L.; Lavitrano M.

Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model
pp. 899-900(2)
Authors: Fiane A.E.; Videm V.; Lambris J.D.; Geiran O.R.; Svennevig J.L.; Mollnes T.E.

A surface-bound form of human C1 esterase inhibitor on xenografts: the complement regulatory function
pp. 901-902(2)
Authors: Matsunami K.; Miyagawa S.; Yamada M.; Nakai R.; Yoshitatsu M.; Shirakura R.

Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection
pp. 903-904(2)
Authors: Verbakel C.A.E.; Bonthuis F.; Eerhart S.E.; van Dixhoorn M.; Grosveld F.; Marquet R.L.; IJzermans J.N.M.

Prevention of hyperacute rejection by phosphatidylinositol-anchored factor I
pp. 905-906(2)
Authors: Yoshitatsu M.; Miyagawa S.; Murase A.; Matsunami K.; Yamada M.; Sawa Y.; Ohtake S.; Matsuda H.; Shirakura R.

Effect of adenovirus-mediated gene transfer with 5I2 gene in guinea pig-to-rat xenotransplantation
pp. 907-908(2)
Authors: Hayashi S.; Kaku L.D.; Namii Y.; Tokoro T.; Kato T.; Kobayashi T.; Yokoyama I.; Okada H.; Nakao A.

Adenovirus-mediated gene transfer of double human complement regulating proteins (DAF, CD59) in xenogeneic rat kidney perfusion
pp. 909-910(2)
Authors: Nagahama M.; Shiraishi M.; Taira K.; Ohshiro T.; Muto Y.

Effects of the endothelin-1 receptor antagonist TAK-044 on pulmonary injury in discordant xenotransplantation
pp. 911-912(2)
Authors: Watanabe T.; Hayasi J.; Isogai A.; Shimizu S.; Takara T.; Asakura T.; Moriya H.; Kubota S.; Yamaguchi S.

Successful generation of transgenic pigs for human decay-accelerating factor and human leucocyte antigen DQ
pp. 913-915(3)
Authors: Tu C.-F.; Hsieh S.-L.; Lee J.-M.; Yang L.-L.; Sato T.; Lee K.-H.; Weng C.-N.; Mao S.J.T.; Tsuji K.; Lee C.-J.

Human CD46 rather than CD55 is a key element in protection against complement activation in vitro
pp. 916-918(3)
Authors: van Dixhoorn M.G.A.; Dekker S.; Janssen R.W.; Verbakel C.A.E.; Grosveld F.

T cells interacting with the -Gal epitope: studies in 1,3Galactosyltransferase knock-out mice
pp. 921-923(3)
Authors: Tanemura M.; Galili U.

T cell repertoire alterations in allograft and xenograft rejection processes
pp. 924-925(2)
Authors: Brouard S.; Sebille F.; Vanhove B.; Gagne K.; Neumann A.U.; Douillard P.; Moreau A.; Cuturi M.C.; Soulillou J.P.

Inhibition of human anti-pig T cell response by anti-CD2, anti-CD40L, and CTLA4-Ig: a comparative study
pp. 926-926(1)
Authors: Xu Y.; Ryan D.; Wu C.; Bazin H.; Latinne D.; White-Scharf M.E.; Thall A.D.

Human monocytes bind to two distinct carbohydrate capping structures on porcine endothelium
pp. 927-927(1)
Authors: Kwiatkowski P.; Artrip J.H.; Wang S.F.; Michler R.E.; Itescu S.

Human natural killer cells augment B cell responses to porcine xenoantigens
pp. 928-928(1)
Authors: John R.; Kwiatkowski P.; Edwards N.; Wang S.F.; Itescu S.

Effect of the remodeling of a glycoantigen on natural killer cell-mediated direct cytotoxicity
pp. 929-930(2)
Authors: Nakai R.; Miyagawa S.; Matsunami K.; Yamada M.; Koma M.; Taniguchi N.; Shirakura R.

Human monocytes bind to ligands on porcine endothelium containing the Gal (1,3)-Gal antigen
pp. 931-931(1)
Authors: Kwiatkowski P.; Artrip J.H.; Michler R.E.; Wang S.F.; McKenzie I.F.C.; Sandrin M.S.; Itescu S.

Analysis of granzyme B and caspases pathway in xenogeneic cytotoxicity
pp. 932-934(3)
Authors: Nakajima H.; Fujiwara I.; Mizuta N.; Sakaguchi K.; Yamagishi H.

Complement- and xenoantibody-independent discordant xenograft rejection in a guinea pig to rat model
pp. 935-935(1)
Authors: Ji P.; Xia G.L.; Waer M.

Identification, detection, and in vitro characterization of cynomolgus monkey natural killer cells in delayed xenograft rejection of hDAF transgenic porcine renal xenografts
pp. 936-937(2)
Authors: Quan D.; Bravery C.; Chavez G.; Richards A.; Cruz G.; Copeman L.; Atkinson C.; Holmes B.; Davies H.; Cozzi E.; White D.

HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection
pp. 938-938(1)
Authors: Dorling A.; Monk N.; Lechler R.

Protection against natural killer-mediated swine endothelial cell lysis by HLA-G and HLA-E
pp. 939-940(2)
Authors: Matsunami K.; Miyagawa S.; Nakai R.; Yamada M.; Shirakura R.

Bcl-2 expression in pig cells suppresses the apoptosis caused by human perforin/granzymes- or FasL/Fas-mediated cytotoxicity
pp. 941-942(2)
Authors: Fujiwara I.; Nakajima H.; Mizuta N.; Sakaguchi K.; Yoshimura N.; Yamagishi H.; Oka T.

Avoidance of graft versus host disease by proper titration of cell and radiation dose in a mouse to rat xeno-chimera
pp. 943-943(1)
Authors: Mohiuddin M.M.; Qian X.; Qin Y.; DiSesa V.J.

Inhibitory effect of cathepsin B inhibitor CA 074 on mouse anti-rat mixed lymphocyte reaction: novel immunosuppressive strategy for indirect xenoantigen recognition
pp. 944-945(2)
Authors: Tohyama T.; Kiyochi H.; Narumoto K.; Honda K.; Kobayashi N.; Kanoh M.; Saibara T.; Katunuma N.

Structural analysis of hyperacute rejection in cardiac xenotransplantation: comparison of two different donor-recipient species combinations
pp. 946-946(1)
Authors: Miyazaki K.; Watanabe S.; Miyatake T.; Watanabe T.; Kubota S.; Murashita T.; Abe K.; Yasuda K.

Modification of antigen-presenting cell functions by heparan sulfate
pp. 947-947(1)
Authors: Kodaira Y.; Platt J.L.

Cellular adhesion and proliferative responses of neonatal human lymphocytes to pig endothelial cells
pp. 948-949(2)
Authors: Xu H.; Fagoaga O.; Gundry S.R.; Bailey L.L.

Human T-cell receptor variable gene analysis against porcine peripheral lymphocytes
pp. 950-951(2)
Authors: Kawagishi N.; Ohkohchi N.; Doi H.; Satomi S.

The role of human T cells in human anti-pig xenogeneic cellular responses
pp. 952-953(2)
Authors: Xu H.; Fagoaga O.; Gundry S.R.; Bailey L.L.

Allosensitization increases human anti-pig cellular xenoreactivity
pp. 954-955(2)
Authors: Popma S.H.; Krasinskas A.M.; Szeto W.Y.; McLean A.D.; Kreisel D.; Kamoun M.; Rosengard B.R.

Transplantation of xenogeneic embryonic thymus to athymic nude mice induces acquisition of distorted immunity
pp. 956-957(2)
Authors: Morimoto T.; Nishigaki-Maki K.; Ohno K.; Ikeda H.; Takeuchi M.; Ueda M.; Takahashi T.; Taguchi O.

Macrophages as an effector mechanism to reject encapsulated hepatoma cells
pp. 958-959(2)
Authors: Yu S.-C.; Chen J.-P.; Liu H.-S.; Hsu B.R.-S.; Fu S.-H.

Immunohistochemical study of a new experimental model of acute cellular xenograft rejection
pp. 960-960(1)
Authors: Ramos A.; Vega A.; Val F.; Chavez G.; Lopez-Hoyos M.; Ruiz J.C.; de Francisco A.L.M.; Castillo J.; Fleitas M.G.; Arias M.

Induction of human T-Cell proliferation by porcine fetal brain cells: role of astrocytes and macrophages/microglia
pp. 961-962(2)
Authors: Brevig T.; Kristensen T.; Zimmer J.

Effect of M-CSF, GM-CSF in adenovirus-mediated gene transfer into macrophages
pp. 963-963(1)
Authors: Shinozuka N.; Kamisasa N.; Akaishi T.; Minoshima T.; Watanabe T.; Matsumoto T.; Anzai H.; Koyama I.; Kyo S.

Histologic comparison of small bowel, heart, and kidney xenografts in a rat to mouse model
pp. 964-964(1)
Authors: Kiyochi H.; Zhang Z.; Jiang J.; Wang H.; Garcia B.; Kellersmann R.; Blomer A.; Zhong R.; Grant D.

Absence of hyperacute rejection and preservation of function in HDAF transgenic pig kidneys exposed to prolonged cold ischaemia
pp. 965-966(2)
Authors: Masroor S.; Cozzi E.; Soin B.; Vial C.; Chavez G.; Smith K.G.C.; Bradley J.R.; G. White D.J.; Friend P.J.

CD39/vascular ATP diphosphohydrolase modulates xenograft survival
pp. 969-969(1)
Authors: Imai M.; Takigami K.; Guckelberger O.; Lin Y.; Sevigny J.; Kaczmarek E.; Goepfert C.; Enjyoji K.; Bach F.H.; Rosenberg R.D.; Robson S.C.

Induction of tissue factor mRNA in acute vascular rejection: localization by in situ reverse transcriptase polymerase chain reaction
pp. 970-970(1)
Authors: Nagayasu T.; Saadi S.; Holzknecht R.A.; Plummer T.B.; Platt J.L.

Regulated endothelial cell expression of novel anticoagulants: a strategy for the prevention and therapy of intravascular thrombosis
pp. 971-971(1)
Authors: Dorling A.; Chen D.; Riesbeck K.; McVey J.; Kemball-Cook G.; Tuddenham E.G.; Lechler R.I.

Platelet heparanase in vascular responses to xenotransplantation
pp. 972-972(1)
Authors: Dempsey L.A.; Plummer T.B.; Coombes S.; Platt J.L.

Apoptosis in acute vascular rejection of xenografts
pp. 973-973(1)
Authors: Holzknecht Z.E.; Williams J.M.; Plummer T.B.; Platt J.L.

Biochemical basis for induction of resistance to human complement in porcine endothelial cells by GAL ligation
pp. 974-974(1)
Authors: Dalmasso A.P.; Benson B.A.; Schroeder A.A.; Abrahamsen M.S.

GAL ligation with a lectin induces activation and resistance to the proinflammatory effects of human complement on porcine endothelium
pp. 975-975(1)
Authors: Grehan J.F.; Kulick D.M.; Guzman-Paz M.; Bolman R.M.; Dalmasso A.P.

Induction of accommodation in the hamster-to-rat model requires inhibition of the membrane attack complex of complement
pp. 976-976(1)
Authors: Suhr B.D.; Guzman-Paz M.; Apasova E.P.; Matas A.J.; Dalmasso A.P.

Identification and characterization of novel porcine molecules specifically regulated on endothelial cells by human complement activation
pp. 977-978(2)
Authors: Boulday G.; Coulon F.; de Martin R.; Soulillou J.P.; Charrreau B.

The major surface-labeled -galactosylated glycoprotein of pig endothelial cells is the 1 integrin subunit
pp. 979-980(2)
Authors: Richard C.; Serhan F.; Barreau N.; Bouhours D.; Bouhours J.-F.

Fluorescence scanner assay for detecting distribution of carbohydrates on porcine endothelial cell
pp. 981-982(2)
Authors: Ogiwara M.; Coles J.G.; Lucien J.; Kadokura M.; Asano H.; Shimada M.; Kyo S.

Effect of extra cellular matrix in adenovirus-mediated gene transfer into endothelial cells
pp. 983-983(1)
Authors: Shinozuka N.; Kamisasa N.; Akaishi T.; Minoshima T.; Watanabe T.; Matsumoto T.; Anzai H.; Koyama I.; Kyo S.

Expression of monocyte chemoattractant protein 1 in pig-to-primate cardiac xenografts
pp. 984-986(3)
Authors: Zhang T.; Suzuki J.; Kawauchi M.; Nakano H.; Kuroda H.; Koide N.; Kitahara H.; Ohta K.; Wada Y.; Tsukioka K.; Takayama K.; Endoh M.; Takamoto S.; Isobe M.; Amano J.

Hepatocyte growth factor and vascular endothelial growth factor expression in pig-to-primate xenotransplanted hearts
pp. 987-989(3)
Authors: Takayama K.; Suzuki J.; Kawauchi M.; Tsukioka K.; Wada Y.; Zhang T.; Endoh M.; Takamoto S.; Amano J.; Isobe M.

Von willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation
pp. 990-990(1)
Authors: Gopfert C.; Buhler L.; Wise R.; Basker M.; Gojo S.; Imai M.; Alwayn I.; Sachs D.H.; Sackstein R.; Cooper D.K.C.; Robson S.C.

Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation
pp. 991-993(3)
Authors: Tanemura M.; Yin D.; Chong A.; Galili U.

Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts
pp. 994-995(2)
Authors: Beschorner W.; Sudan D.; Yang T.; Radio S.; Stammers A.; Johnson N.; Shearon C.; Kuszynski C.; Dixon R.S.; Matamoros A.; Langnas A.

Altered expression of matrix metalloproteinases in pig-to-primate xenotransplanted hearts
pp. 996-998(3)
Authors: Tsukioka K.; Suzuki J.; Kawauchi M.; Wada Y.; Zhang T.; Endoh M.; Takayama K.; Takamoto S.; Isobe M.; Amano J.

Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA₂ inhibitor/antagonists, and nitroglycerin
pp. 999-1000(2)
Authors: Miyatake T.; Kubota S.; Miyazaki K.; Watanabe S.; Mafune N.; Murashita T.; Yasuda K.

Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation
pp. 1003-1004(2)
Authors: Yin D.P.; Sankary H.N.; Shen J.; Ma L.L.; Blinder L.; Foster P.; Williams J.W.; Chong A.

Nondepleting anti-CD4 but not anti-CD8 antibody induces long-term survival of xenogeneic and allogeneic hearts in 1,3-galactosyl-transferase knock-out mice
pp. 1005-1005(1)
Authors: Chong A.S.-F.; Ma L.; Yin D.; Shen J.; Blinder L.; XiuLong X.; Williams J.; Byrne G.; Diamond L.; Logan J.

Costimulatory signal blockade by anti-CD2 monoclonal antibody in combination with 15-deoxyspergualin prolongs concordant xenograft survival
pp. 1006-1008(3)
Authors: Haga M.; Hirahara H.; Tsuchida M.; Watanabe T.; Takekubo M.; Hayashi J.

Effect of B cell/plasma cell depletion or suppression on Anti-Gal antibody in the baboon
pp. 1009-1009(1)
Authors: Basker M.; Alwayn I.P.J.; Treter S.; Harper D.; Buhler L.; Andrews D.; Thall A.; Lambrigts D.; Awwad M.; White-Scharf M.; Sachs D.H.; Cooper D.K.C.

Effects of pretransplant splenectomy and immunosuppression of humoral immunity in a pig-to-newborn goat cardiac xenograft model
pp. 1010-1014(5)
Authors: Xu H.; Gundry S.R.; Hancock W.W.; Zuppan C.; Izutani H.; Bailey L.L.

Cyclosporine induces long-term xenograft survival in the mouse-to-C6-deficient rat heart transplantation model
pp. 1015-1015(1)
Authors: Wu G.S.; Korsgren O.; Tibell A.

Macrophage depletion prevents accelerated rejection and results in long-term survival in hamster to rat cardiac xenotransplantation
pp. 1016-1016(1)
Authors: Takayama J.; Koyamada N.; Abe T.; Hatsugai K.; Usuda M.; Ohkohchi N.; Satomi S.

FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model
pp. 1017-1017(1)
Authors: Zhang J.; Song Z.; Wijkstrom M.; Bari S.; Sundberg B.; Nava S.; Groth C.G.; Korsgren O.; Wennberg L.

WF10 in xenotransplantation-a potential new approach
pp. 1018-1019(2)
Authors: Kemp E.; Dieperink H.; Horn T.; Johansen A.; Jensen J.; Kemp G.; Larsen S.; Lillevang S.; Svendsen M.; Freilow E.; Kuhlmann I.; Kemp K.

Simple therapy for cardiac concordant xenotransplantation: only 1 week of DSG administration with suppression of t-cell reactions
pp. 1020-1020(1)
Authors: Kubota S.; Miyatake T.; Miyazaki K.; Watanabe T.; Mafune N.; Watanabe S.; Abe K.; Murashita T.; Yasuda K.

Does adenovirus-mediated viral IL-10 gene transfer prolong survival of xenogeneic spheroidal aggregate-cultured hepatocytes?
pp. 1021-1023(3)
Authors: Okada Y.; Saito S.; Fujisawa K.; Yagi T.; Tanaka N.

Efficacy of malononitriloamide 279 and 715 in islet xenotransplantation: a study in the pig-to-rat model
pp. 1024-1024(1)
Authors: Wijkstrom M.; Song Z.; Zhang J.; Bari S.; Sundberg B.; Groth C.G.; Korsgren O.; Wennberg L.

Protective effect of FK-506 in pig-to-rat islet xenotransplantation is abrogated by prednisolone
pp. 1025-1025(1)
Authors: Song Z.; Wennberg L.; Zhang J.; Sundberg B.; Bari S.; Groth C.G.; Korsgren O.

Brequinar in combination with cyclosporine a inhibits islet xenograft rejection for up to 24 days: a study in the pig-to-rat model
pp. 1026-1026(1)
Authors: Wennberg L.; Song Z.; Wijkstrom M.; Zhang J.; Bari S.; Sundberg B.; Groth C.G.; Korsgren O.

Multilineage bone marrow chimerism produces cellular and humoral tolerance in a mouse-to-rat cardiac xenograft
pp. 1029-1030(2)
Authors: Mohiuddin M.M.; Qian X.; Qin Y.; DiSesa V.J.

Induction of combined T-Cell-Dependent and T-Cell-Independent xenograft tolerance by thymus/heart composite grafts
pp. 1031-1031(1)
Authors: Xia G.L.; Vandeputte M.; Waer M.

Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease
pp. 1032-1033(2)
Authors: Lee Y.-H.; Miki T.; Kuddus R.; Tandin A.; Goller A.L.; Subbotin V.; Fung J.J.; Peach R.; Valdivia L.A.; Rao A.S.

Blood transfusion effect on xenograft survival in athymic nude rats is mediated by humoral factors
pp. 1034-1034(1)
Authors: Vriens P.W.; Stoot J.H.; Bouwman E.; Robbins R.C.

Oral delivery of xenoantigen combined with non-depleting Anti-CD4 monoclonal antibody induced significant prolonged survival of concordant skin xenografts
pp. 1035-1035(1)
Authors: Niimi M.; Shirasugi N.; Hamano K.; Esato K.; Matsumoto K.; Ikeda Y.; Shatari T.; Takami H.; Kodaira S.

Xenogeneic humoral Graft-Vs-Host disease following Hamster-to-Rat bone marrow transplantation
pp. 1036-1037(2)
Authors: Miki T.; Lee Y.-H.; Tandin A.; Subbotin V.; Kuddus R.; Rao A.S.; Fung J.J.; Starzl T.E.; Valdivia L.A.

Synergistic effect of pretransplant xenogeneic blood transfusion with NK cell and/or B-Cell immunosuppression to modulate T-Cell-independent xenoreactivity
pp. 1038-1038(1)
Authors: Xia G.L.; Ji P.; Vandeputte M.; Waer M.

Partial deletion of donor T cells in the recipient thymus in fully xenogeneic mouse-to-rat chimeras
pp. 1039-1039(1)
Authors: Mohiuddin M.M.; Qian X.; Qin Y.; DiSesa V.J.

Human parathyroid grafts survived and functioned in mice treated with Anti-CD4 monoclonal antibody
pp. 1040-1040(1)
Authors: Niimi M.; Takashina M.; Shirasugi N.; Hamano K.; Esato K.; Matsumoto K.; Ikeda Y.; Takami H.; Kodaira S.; Kameyama K.

Targeted transgene expression using the human HLA-DRA promoter in a retroviral vector
pp. 1041-1042(2)
Authors: Muthukumar S.; Denaro M.; Banerjee P.T.; White-Scharf M.E.; Andersson G.

In vitro differentiation of human lymphocytes in a porcine microenvironment: implication for xenogeneic organ transplantation
pp. 1043-1044(2)
Authors: Kuhn C.; Teszmann R.; DallaRiva C.; Glaubitz M.; Martin U.; Steinhoff G.; Haverich A.; Simon A.R.

Increases in autologous hematopoietic progenitors in the blood of baboons following irradiation and treatment with porcine stem cell factor and interleukin-3
pp. 1045-1046(2)
Authors: Down J.D.; Awwad M.; Kurilla-Mahon B.; Moran K.; Ericsson T.; Oldmixon B.; Lachance A.; Watts A.; Treter S.; Nash K.; Gojo S.; Sachs D.H.; White-Scharf M.E.; Cooper D.K.C.

Porcine stem cell factor facilitates long-lasting porcine hematopoietic engraftment in murine recipients
pp. 1047-1047(1)
Authors: Abe M.; Chen A.M.; Qi J.; Sachs D.H.; Sykes M.; Yang Y.-G.

Experience with porcine thymic transplantation in baboons
pp. 1048-1048(1)
Authors: Wu A.; Yamada K.; Awwad M.; Shimizu A.; Watts A.; Murphy M.; Gojo S.; Neville D.; Cooper D.K.C.; Sykes M.; Sachs D.H.

Probable failure of chimerism induction in orthotopically transplanted monkey hearts in baboons
pp. 1049-1051(3)
Authors: Izutani H.; Gundry S.R.; Asano M.; Fagoaga O.; Zuppan C.W.; Bailey L.L.

An attempt to induce peripheral tolerance in a pig-to-primate transplantation model by infusion of ultrahigh numbers of donor peripheral blood mononuclear cells: first promising results
pp. 1052-1053(2)
Authors: Simon A.R.; Schroder C.; Martin U.; Chikobava M.; Templin C.; Laaf G.; Kohl J.; Lapin B.; Haverich A.; Steinhoff G.

VLA-Integrin -1 chain function is not fully conserved between the human and porcine species: implications for xenotransplantation
pp. 1054-1055(2)
Authors: Dalla Riva C.; Tessmann R.; Kuehn C.; Martin U.; Diehl A.-M.; Steinhoff G.; Haverich A.; Simon A.R.

A novel model mimicking the immunoreactivity in pig-to-human xenotransplantation
pp. 1056-1057(2)
Authors: Cheng J.; Ma Y.; Li Y.; Li S.; He Q.; Shen W.

RYR1 genotype of the Chinese neijiang pig
pp. 1058-1058(1)
Authors: Bu H.; Chen Y.; Liu J.; Li S.; Cheng J.; Li Y.

Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days
pp. 1061-1061(1)
Authors: Wennberg L.; Song Z.; Zhang J.; Bennet W.; Nava S.; Bari S.; Sundberg B.; Korsgren O.; Groth C.G.

Murine chemokine gene expression in rejecting pig proislet xenografts
pp. 1062-1062(1)
Authors: Paule M.F.; McColl S.R.; Simeonovic C.J.

Ultrastructural identification of cells expressing Gal1-3Gal antigen in cultured fetal porcine isletlike cell clusters
pp. 1063-1063(1)
Authors: Strokan V.; Bennet W.; Molne J.; Korsgren O.; Breimer M.E.

Xenografting of pig islets in monkeys does not result in hyperacute rejection
pp. 1064-1064(1)
Authors: Rijkelijkhuizen J.K.R.A.; Ossevoort M.; Ringers J.; van der Burg M.P.M.; Kuhn E.M.; Wubben J.; Haanstra K.; Bouwman E.; Jonker M.

Porcine islets of Langerhans isolated from normal and hDAF transgenic pigs elicit the same acute inflammatory reaction during exposure to human blood; inhibition of the response with soluble complement receptor 1 and heparin
pp. 1065-1065(1)
Authors: Bennet W.; Sundberg B.; Song Z.; Elgue G.; Wennberg L.; Richards A.; White D.J.; Larsson R.; Nilsson B.; Groth C.-G.; Korsgren O.

Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum
pp. 1066-1066(1)
Authors: Bennet W.; Sundberg B.; Elgue G.; Brendel M.; Richards A.; White D.J.; Groth C.-G.; Korsgren O.

Avipox virus vectors for gene delivery to fetal mouse and pig proislets
pp. 1067-1067(1)
Authors: Paule M.F.; Ramshaw I.A.; Simeonovic C.J.

Xenographic survival and function of transplanted monkey pancreatic islets in rats
pp. 1068-1068(1)
Authors: Balamurugan A.N.; Remington E.J.; Ramakrishna B.; Gunasekaran S.

Role of macrophages and natural killer cells in the rejection of pig islet xenografts in mice
pp. 1069-1069(1)
Authors: Wu G.S.; Korsgren O.; Zhang J.G.; Song Z.S.; Van Rooijen N.; Tibell A.

Pig-to-rabbit islet transplantation as an immunologic model of pig-to-human islet xenografts
pp. 1070-1070(1)
Authors: Papalois V.E.; Lee J.; McKane W.; Browning N.; Palmer A.; Hakim N.; Cairns T.; Taube D.

Efficacy of agarose/polystyrene sulfonic acid microencapsulation for islet xenotransplantation
pp. 1071-1072(2)
Authors: Aomatsu Y.; Nakajima Y.; Ohyama T.; Kin T.; Kanehiro H.; Hisanaga M.; Ko S.; Nagao M.; Tatekawa Y.; Sho M.; Ikeda N.; Kanokogi H.; Kobayashi T.; Urizono Y.; Yamada T.; Shibaji T.; Kanamura T.; Ogawa S.; Iwata H.; Nakano H.

Beneficial effects of pentoxiphylline on islet transplantation
pp. 1073-1075(3)
Authors: Juang J.-H.; Kuo C.-H.; Hsu B.R.-S.

Role of nonimmunological factors in islet graft failure
pp. 1076-1078(3)
Authors: Juang J.-H.; Kuo C.-H.; Hsu B.R.-S.

The role of species barrier on the development of pericapsular neogrowth of encapsulated islets
pp. 1079-1080(2)
Authors: Hsu B.R.S.; Juang J.H.; Fu S.H.; Kuo C.H.; Wan P.; Hsu S.; Hsu A.W.

Transendothelial migration and infiltration of porcine xenografts by primate monocytes requires natural killer cell-dependent activation
pp. 1083-1083(1)
Authors: Itescu S.; Kwiatkowski P.; Artrip J.H.; Kocher A.; Edwards N.; Michler R.E.

Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion
pp. 1084-1085(2)
Authors: Xu H.; Gundry S.R.; Hancock W.; Matsumiya G.; Bailey L.L.

Perioperative monitoring of cardiac function during discordant pig-to-primate kidney xenotransplantation using transpulmonary thermodilution
pp. 1086-1086(1)
Authors: Przemeck M.; Loss M.; Vangerow B.; Ruckoldt H.; Klempnauer J.; Winkler M.; Piepenbrock S.

Technique of immunoapheresis in heterotopic and orthotopic xenotransplantation of pig hearts into cynomolgus and rhesus monkeys
pp. 1087-1088(2)
Authors: Brenner P.; Schmoeckel M.; Reichenspurner H.; Felbinger T.; Hinz M.; Eder V.; Rucker A.; Wimmer C.; Uchita S.; Kriegeskorte S.; Meiser B.; Muller-Hocker J.; Seidel D.; Hammer C.; Reichart B.

Expression of the transcriptional factor Egr-1/BTEB2 in cardiac xenograft vascular remodeling
pp. 1089-1091(3)
Authors: Wada Y.; Suzuki J.; Tsukioka K.; Zhang T.; Takayama K.; Endoh M.; Watanabe N.; Kurabayashi M.; Kawauchi M.; Nagai R.; Takamoto S.; Isobe M.; Amano J.

Nonmuscle myosin heavy chain and nuclear factor-kappa B expression in pig-to-primate xenotransplanted hearts
pp. 1092-1094(3)
Authors: Takayama K.; Suzuki J.; Kawauchi M.; Tsukioka K.; Wada Y.; Zhang T.; Endoh M.; Takamoto S.; Amano J.; Isobe M.

Long-term survival of cynomolgus monkeys following pig-to-primate kidney xenotransplantation using h-DAF transgenic donor organs
pp. 1095-1096(2)
Authors: Loss M.; Przemeck M.; Schmidtko J.; Arends H.; Kunz R.; Jager K.; Jalali A.; Rensing S.; Kaup J.; Cozzi E.; White D.J.G.; Klempnauer J.; Winkler M.

Comparative study of antibody removal before pig-to-baboon and human ABO-incompatible renal transplantation
pp. 1097-1097(1)
Authors: Kobayashi T.; Yokoyama I.; Nagasaka T.; Liu D.; Kato T.; Tokoro T.; Namii Y.; Hayashi S.; Nakao A.; Morozumi K.; Oikawa T.; Usami T.; Takeuchi O.; Katayama A.; Haba T.; Tominaga Y.; Uchida K.; Takagi H.

Factors determining the onset of hyperacute rejection following discordant porcine-to-cynomolgus monkey kidney xenotransplantation
pp. 1098-1098(1)
Authors: Loss M.; Przemeck M.; Schmidtko J.; Kunz R.; Jalali A.; Arends H.; Lorenz R.; Rensing S.; Kaup F.J.; Jager K.; White D.J.G.; Klempnauer J.; Winkler M.

Coagulation/thrombotic disorders associated with organ and cell xenotransplantation
pp. 1099-1099(1)
Authors: Alwayn I.P.J.; Buhler L.; Basker M.; Goepfert C.; Kawai T.; Kozlowski T.; Ierino F.; Sachs D.H.; Sackstein R.; Robson S.C.; Cooper D.K.C.

A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons
pp. 1100-1100(1)
Authors: Buhler L.; Awwad M.; Basker M.; Gojo S.; Thall A.; Down J.D.; Sykes M.; Andrews D.; Sackstein R.; White-Scharf M.E.; Sachs D.H.; Cooper D.K.C.

Induction of mixed hematopoietic chimerism in the pig-to-baboon model
pp. 1101-1101(1)
Authors: Buhler L.; Awwad M.; Treter S.; Basker M.; Ericson T.; Lachance A.; Oldmixon B.; Kurilla-Mahon B.; Gojo S.; Huang C.; Thall A.; Down J.D.; White-Scharf M.E.; Sachs D.H.; Cooper D.K.C.

Injection of porcine anti-idiotypic antibodies to primate anti-Gal antibodies leads to active inhibition of serum cytotoxicity in a baboon
pp. 1102-1102(1)
Authors: Buhler L.; Treter S.; McMorrow I.; Neethling F.A.; Alwayn I.; Awwad M.; Thall A.; Cooper D.K.C.; LeGuern C.; Sachs D.H.

Human-pig spleen transplantation leading to high level of chimerism
pp. 1103-1104(2)
Authors: Li Y.; Wang K.; Cheng J.; Li F.; Ma Y.; Yang Y.

Preparation of bioartificial liver using hollow fibers with four different cut-off molecular weights
pp. 1107-1108(2)
Authors: Iwata H.; Ueda Y.; Sajiki T.; Paek H.J.; Fujita S.; Zhu B.; Kanazawa A.; Ikai I.; Yamaoka Y.; Ikada Y.

Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia
pp. 1109-1109(1)
Authors: Tandin A.; Goller A.L.; Miki T.; Lee Y.-H.; Kovscek A.M.; Fung J.J.; Starzl T.E.; Valdivia L.A.

Loss of serum bicarbonate after discordant liver xenotransplantation
pp. 1110-1110(1)
Authors: Goller A.L.; Miki T.; Tandin A.; Lee Y.-H.; Kovscek A.M.; Fung J.J.; Starzl T.E.; Valdivia L.A.

Attenuation of hepatic microcirculatory failure during in situ xenogeneic rat liver perfusion by heat shock preconditioning
pp. 1111-1111(1)
Authors: Terajima H.; Thiaener A.; Hammer C.; Messmer K.; Yamamoto Y.; Yamaoka Y.

The porcine liver supports metabolic homeostasis in the nonhuman primate: experimental study in a model of orthotopic liver transplantation from h-DAF transgenic pig to baboon
pp. 1112-1113(2)
Authors: Ramirez P.; Chavez R.; Majado M.; Munitiz V.; Munoz A.; Hernandez Q.; Palenciano C.; Pino-Chavez G.; Loba M.; Minguela A.; Yelamos J.; Vizcaino A.S.; Asensi H.; Cayuela M.G.; Segura B.; Marin F.; Rubio A.; Rios A.; Fuente T.; Robles R.; Sanchez F.; Sansano T.; Acosta F.; Rodriguez J.M.; Navarro F.; Cabezuelo J.; Cozzi E.; White D.J.G.; Calne R.Y.; Parrilla P.

Acute liver failure attenuates hyperacute xenograft rejection
pp. 1114-1115(2)
Authors: Stockmann H.B.A.C.; Hiemstra C.A.; Meijer R.; Marquet R.L.; IJzermans J.N.M.

Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion
pp. 1116-1117(2)
Authors: Shiraishi M.; Nagahama M.; Nozato E.; Oshiro T.; Taira K.; Muto Y.

Intraperitoneal transplantation of microencapsulated xenogeneic hepatocytes in totally hepatectomized rats
pp. 1118-1120(3)
Authors: Aoki K.; Hakamada K.; Umehara Y.; Seino K.; Itabashi Y.; Sasaki M.

Establishment of a reversibly immortalized human hepatocyte cell line by using cre/loxp site-specific recombination
pp. 1121-1122(2)
Authors: Kobayashi N.; Noguchi H.; Fujiwara T.; Tanaka N.

Xenotransplantation of immortalized human hepatocytes for experimental acute liver failure in rats
pp. 1123-1124(2)
Authors: Kobayashi N.; Noguchi H.; Fujiwara T.; Tanaka N.

Three-stage total hepatectomy using a portocaval shunt tube in rats
pp. 1125-1126(2)
Authors: Umehara Y.; Hakamada K.; Toyoki Y.; Seino K.; Aoki K.; Sasaki M.

Rearterialization of hepatic xenografts in the combination of hamster-to-rat
pp. 1127-1128(2)
Authors: Fudaba Y.; Ohdan H.; Tashiro H.; Miyata Y.; Shibata S.; Shintaku S.; Mizunuma K.; Ito H.; Fukuda Y.; Asahara T.; Dohi K.

Analysis of hyperacute rejection in newborn pig-to-dog lung xenotransplantation
pp. 1131-1140(10)
Authors: Nakajima R.; Nakajima S.; Nagata S.; Miura T.; Hirano T.; Konaka C.; Tsuji K.; Kato H.

Evidence of immunocomplex formation in pulmonary xenografts
pp. 1141-1141(1)
Authors: Holzknecht Z.E.; Coombes S.; Blocher B.A.; Plummer T.B.; Bustos M.; Lau C.L.; Davis R.D.; Platt J.L.

Xeno ex vivo perfusion model in immature and mature porcine lung with human red blood cells and serum
pp. 1142-1148(7)
Authors: Nagata S.; Nakajima S.; Miura T.; Nakajima R.; Hirano T.; Konaka C.; Tsuji K.; Kato H.

Ex vivo perfusion of swine lungs: lung function in a pig-to-human model of xenotransplantation
pp. 1149-1150(2)
Authors: Wiebe K.; Steinhoff G.; Poeling J.; Schroder C.; Meliss R.; Winkler M.; Haverich A.

Nonmuscle myosin heavy chain and metalloproteinase-2 expression in concordant pulmonary xenografts
pp. 1151-1152(2)
Authors: Endoh M.; Kawauchi M.; Isobe M.; Suzuki J.; Nakajima J.; Takeda M.; Takamoto S.

Potential risk of xenotransplant-associated infections
pp. 1155-1156(2)
Author: Yamanouchi K.

Transmission of pig endogenous retrovirus to primary human cells
pp. 1157-1157(1)
Authors: Martin U.; Winkler M.E.; Id M.; Radecke H.; Arseniev L.; Groteluschen R.; Simon A.R.; Steinhoff G.

Molecularly cloned porcine endogenous retroviruses replicate on human cells
pp. 1158-1161(4)
Authors: Tonjes R.R.; Czauderna F.; Fischer N.; Krach U.; Boller K.; Chardon P.; Rogel-Gaillard C.; Niebert M.; Scheef G.; Werner A.; Kurth R.

Porcine endogenous retrovirus is not transmitted in a discordant porcine-to-cynomolgus xenokidney transplantation model with long-term survival of organ recipients
pp. 1162-1162(1)
Authors: Winkler M.E.; Martin U.; Loss M.; Arends H.; Rensing S.; Kaup F.J.; Hedrich H.J.; Klempnauer J.; Winkler M.

Analysis of potential porcine endogenous retrovirus transmission to baboon in vitro and in vivo
pp. 1163-1164(2)
Authors: Templin C.; Schroder C.; Simon A.R.; Laaff G.; Kohl J.; Chikobava M.; Lapin B.; Steinhoff G.; Martin U.

Investigations on biological safety and immunologic aspects of chimeric bioartificial vessels in xenotransplantation
pp. 1165-1165(1)
Authors: Mertsching H.; Karim N.; Haverich A.; Bader A.

Porcine endogenous retroviruses: diagnostic assays and evidence for immunosuppressive properties
pp. 1166-1166(1)
Authors: Tacke S.; Specke V.; Stephan O.; Seibold E.; Bodusch K.; Denner J.

Current applications of cellular xenografts
pp. 1169-1171(3)
Author: Edge A.S.B.

Xenotransplantation and animal welfare
pp. 1172-1173(2)
Author: Olsson K.

Neural tissue xenografting in neurodegenerative disorders: countdown to a clinical trial
pp. 1174-1174(1)
Author: Widner H.

Attitudes to xenotransplantation: interviews with patients suffering from parkinson's disease focusing on the conception of risk
pp. 1175-1176(2)
Authors: Lundin S.; Widner H.

Future of xenotransplantation: what are the ethical problems?
pp. 1177-1178(2)
Author: Welin S.

Erratum
pp. 1179-1179(1)